Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chrishan S Samuel

Showing results (31-40 of 173) with videos related to

Pageof 18
Sort By:
Biochemical Pharmacology|March 15, 2024
The involvement of the Wnt/β-catenin signaling cascade in fibrosis progression and its therapeutic targeting by relaxinDeidree V N Somanader, Peishen Zhao, Robert E Widdop, et al.
International Journal of Molecular Sciences|July 9, 2022
Relaxin Inhibits the Cardiac Myofibroblast NLRP3 Inflammasome as Part of Its Anti-Fibrotic Actions via the Angiotensin Type 2 and ATP (P2X7) ReceptorsFelipe Tapia Cáceres, Tracey A Gaspari, Mohammed Akhter Hossain, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 5, 2009
Lectin histochemistry for light and electron microscopySu Ee Wong, Catherine E Winbanks, Chrishan S Samuel, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 16, 2019
iPSC- and mesenchymoangioblast-derived mesenchymal stem cells provide greater protection against experimental chronic allergic airways disease compared with a clinically used corticosteroidSimon G Royce, WeiYi Mao, Rebecca Lim, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|January 24, 2014
Therapeutic effects of serelaxin in acute heart failureXiao-Jun Du, Tim D Hewitson, My-Nhan Nguyen, et al.
Clinical Science (London, England : 1979)|July 24, 2012
Combination therapy with relaxin and methylprednisolone augments the effects of either treatment alone in inhibiting subepithelial fibrosis in an experimental model of allergic airways diseaseSimon G Royce, Amelia Sedjahtera, Chrishan S Samuel, et al.
Molecular and Cellular Endocrinology|January 24, 2012
The regulation of fibrosis in airway remodeling in asthmaSimon G Royce, Victor Cheng, Chrishan S Samuel, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 6, 2019
Serelaxin inhibits the profibrotic TGF-β1/IL-1β axis by targeting TLR-4 and the NLRP3 inflammasome in cardiac myofibroblastsFelipe Tapia Cáceres, Tracey A Gaspari, Chrishan S Samuel, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 18, 2015
Qualitative and Quantitative Analysis of Histone Deacetylases in Kidney Tissue SectionsKatherine Ververis, Selly Marzully, Chrishan S Samuel, et al.
Pharmacology & Therapeutics|July 4, 2006
'Relaxin' the stiffened heart and arteries: the therapeutic potential for relaxin in the treatment of cardiovascular diseaseChrishan S Samuel, Xiao-Jun Du, Ross A D Bathgate, et al.
Pageof 18

Showing results (31-40 of 173) with videos related to

Sort By:
Pageof 18
Biochemical Pharmacology|March 15, 2024
The involvement of the Wnt/β-catenin signaling cascade in fibrosis progression and its therapeutic targeting by relaxinDeidree V N Somanader, Peishen Zhao, Robert E Widdop, et al.
International Journal of Molecular Sciences|July 9, 2022
Relaxin Inhibits the Cardiac Myofibroblast NLRP3 Inflammasome as Part of Its Anti-Fibrotic Actions via the Angiotensin Type 2 and ATP (P2X7) ReceptorsFelipe Tapia Cáceres, Tracey A Gaspari, Mohammed Akhter Hossain, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 5, 2009
Lectin histochemistry for light and electron microscopySu Ee Wong, Catherine E Winbanks, Chrishan S Samuel, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 16, 2019
iPSC- and mesenchymoangioblast-derived mesenchymal stem cells provide greater protection against experimental chronic allergic airways disease compared with a clinically used corticosteroidSimon G Royce, WeiYi Mao, Rebecca Lim, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|January 24, 2014
Therapeutic effects of serelaxin in acute heart failureXiao-Jun Du, Tim D Hewitson, My-Nhan Nguyen, et al.
Clinical Science (London, England : 1979)|July 24, 2012
Combination therapy with relaxin and methylprednisolone augments the effects of either treatment alone in inhibiting subepithelial fibrosis in an experimental model of allergic airways diseaseSimon G Royce, Amelia Sedjahtera, Chrishan S Samuel, et al.
Molecular and Cellular Endocrinology|January 24, 2012
The regulation of fibrosis in airway remodeling in asthmaSimon G Royce, Victor Cheng, Chrishan S Samuel, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 6, 2019
Serelaxin inhibits the profibrotic TGF-β1/IL-1β axis by targeting TLR-4 and the NLRP3 inflammasome in cardiac myofibroblastsFelipe Tapia Cáceres, Tracey A Gaspari, Chrishan S Samuel, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 18, 2015
Qualitative and Quantitative Analysis of Histone Deacetylases in Kidney Tissue SectionsKatherine Ververis, Selly Marzully, Chrishan S Samuel, et al.
Pharmacology & Therapeutics|July 4, 2006
'Relaxin' the stiffened heart and arteries: the therapeutic potential for relaxin in the treatment of cardiovascular diseaseChrishan S Samuel, Xiao-Jun Du, Ross A D Bathgate, et al.
Pageof 18